Nothing Is Undruggable: Novartis' Bradner On CAR-T, CRISPR & DNA Libraries

 
• By Sten Stovall
  
James Bradner, President of the Novartis Institutes for BioMedical Research (NIBR)
James Bradner, President, Novartis Institutes for BioMedical Research (NIBR) • Source: Novartis AG
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip